1. Home
  2. FRSX vs SYBX Comparison

FRSX vs SYBX Comparison

Compare FRSX & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRSX
  • SYBX
  • Stock Information
  • Founded
  • FRSX N/A
  • SYBX N/A
  • Country
  • FRSX Israel
  • SYBX United States
  • Employees
  • FRSX N/A
  • SYBX N/A
  • Industry
  • FRSX Computer Software: Prepackaged Software
  • SYBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FRSX Technology
  • SYBX Health Care
  • Exchange
  • FRSX Nasdaq
  • SYBX Nasdaq
  • Market Cap
  • FRSX 11.4M
  • SYBX 13.6M
  • IPO Year
  • FRSX 2017
  • SYBX N/A
  • Fundamental
  • Price
  • FRSX $0.53
  • SYBX $1.15
  • Analyst Decision
  • FRSX
  • SYBX
  • Analyst Count
  • FRSX 0
  • SYBX 0
  • Target Price
  • FRSX N/A
  • SYBX N/A
  • AVG Volume (30 Days)
  • FRSX 197.8K
  • SYBX 12.5K
  • Earning Date
  • FRSX 06-10-2025
  • SYBX 06-10-2025
  • Dividend Yield
  • FRSX N/A
  • SYBX N/A
  • EPS Growth
  • FRSX N/A
  • SYBX N/A
  • EPS
  • FRSX N/A
  • SYBX 0.21
  • Revenue
  • FRSX $436,000.00
  • SYBX N/A
  • Revenue This Year
  • FRSX N/A
  • SYBX N/A
  • Revenue Next Year
  • FRSX N/A
  • SYBX N/A
  • P/E Ratio
  • FRSX N/A
  • SYBX $5.49
  • Revenue Growth
  • FRSX N/A
  • SYBX N/A
  • 52 Week Low
  • FRSX $0.51
  • SYBX $0.90
  • 52 Week High
  • FRSX $2.63
  • SYBX $1.88
  • Technical
  • Relative Strength Index (RSI)
  • FRSX 34.56
  • SYBX 52.17
  • Support Level
  • FRSX $0.53
  • SYBX $1.00
  • Resistance Level
  • FRSX $0.66
  • SYBX $1.20
  • Average True Range (ATR)
  • FRSX 0.06
  • SYBX 0.05
  • MACD
  • FRSX -0.01
  • SYBX 0.01
  • Stochastic Oscillator
  • FRSX 10.70
  • SYBX 75.00

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Share on Social Networks: